您的位置: 首页 > 农业专利 > 详情页

TRISPEZIFISCHE INHIBITOREN ZUR KREBSBEHANDLUNG
专利权人:
Gensun Biopharma Inc.
发明人:
SHENG, Jackie,LIU, Bo,JIA, Haiqun
申请号:
EP17771178
公开号:
EP3432927A4
申请日:
2017.03.23
申请国别(地区):
EP
年份:
2019
代理人:
摘要:
A trispecific inhibitor for treating cancer includes a first targeting domain having a binding specificity conferred by a VEGF binding antagonist; a second targeting domain having a binding specificity conferred by an immune checkpoint regulator binding antagonist; and a third targeting domain having a binding specificity conferred by a Tie2 tyrosine kinase receptor binding antagonist. The targeting domains may contain one or more antibody variable regions, peptide inhibitors, dominant negative proteins, small molecule drugs or combinations thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充